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Özet
Amaç: Bu çalışmada juvenil miyoklonik epilepsi (JME) hastalarında fokal klinik bulgular ve elektroensefalografik (EEG) özelliklerin prognoz ile 
ilişkilerini araştırmayı amaçladık.
Gereç ve Yöntem: Geriye dönük olarak 110 JME hastasının klinik ve EEG özellikleri incelendi ve her bir nöbet tipi ve gelişimi semiyolojik nö-
bet sınıflamasına göre sınıflandırıldı. Fokal semiyoljik özellikler ve fokal interiktal EEG bulguları olan hastalar belirlendi. 
Bulgular: On beş hastada (%13.6) fokal klinik özellikler, 13 hasta (%11.8) izole fokal EEG anormallikleri mevcuttu. Hastalar prognoz özellikleri-
ne göre; nöbetsiz, iyi prognoz ve kötü prognoz olarak üç grupta sınıflandırıldı. Kötü prognozu olan 10 hastanın 9’unda (%90) fokal klinik özel-
likler, fokal EEG özellikleri veya ikisi birden mevcuttu.
Sonuç: Bizim çalışmamız auralar haricindeki fokal klinik özelliklerin, jeneralize EEG anormallikleri ile birlikte fokal veya asimetrik EEG özellik-
lerinin ve özellikle de izole fokal EEG anormalliklerin kötü prognozu öngörebileceğini desteklemektedir. 
Anahtar sözcükler: Elektroensefalografi; fokal özellikler; juvenil myoklonik epilepsi; prognoz.
Summary
Objectives: Our aim was to investigate the relationship between the focal clinical findings and electroencephalographic (EEG) features of 
patients with juvenile myoclonic epilepsy (JME) and their prognosis. 
Methods: We retrospectively studied the clinical and EEG features of 110 patients with JME and classified each seizure type and its evolution 
according to the semiologic seizure classification. Focal semiologic features and focal interictal EEG findings were defined in each patient. 
Results: Fifteen patients (13.6%) had focal clinical features, and 13 patients (11.8%) had isolated focal EEG abnormalities. Regarding their 
prognosis, patients were classified into three groups: seizure free, good prognosis, or poor prognosis. Ten patients had a poor prognosis, and 
9 (90%) of those patients exhibited focal clinical features, focal EEG features, or both. 
Conclusion: Our study supported that focal clinical features, except the presence of auras, and focal or asymmetrical features plus general-
ized EEG abnormalites, especially isolated focal EEG features, as suggestive of a poor prognosis. 
Key words: Electroencephalography; focal features; juvenile myoclonic epilepsy; prognosis.
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Juvenile  myoclonic  epilepsy  (JME)  is  a  hereditary,  idio-
pathic, generalized form of epilepsy and is estimated to ac-
count for approximately 10% of all epilepsies, with a range 
of 4% to 11%.[1] Seizures have an age-related onset and are 
characterized by the triad of myoclonic jerks on awaken-
ing,  generalized  tonic-clonic  seizures  (GTC),  and  typical 
absence  seizures.  In  classical  cases  of  JME,  the  seizures 
are usually bilateral and symmetrical, and the electroen-
cephalographic (EEG) findings reveal generalized interictal 
epileptiform discharges and a generalized seizure pattern 
that is bilaterally synchronous.[2]
The presence of focal EEG abnormalities and focal clinical 
features often cause difficulties and errors in the diagnosis 
of JME.[3] Despite well-defined clinical and EEG features of 
patients with JME, only a few reports have addressed the 
prognosis for these patients.[4-8] 
In this study, we aimed to investigate the relationship be-
tween the focal clinical findings and EEG features of pa-
tients with JME and their prognosis.
Materials and Methods
We retrospectively analyzed 2581 charts of patients in our 
Epilepsy Department, with the aim of identifying patients 
with a diagnosis of JME. Between May 1995 and October 
2008,  144  patients  of  our  Outpatient  Department  were 
diagnosed with JME. The criteria for exclusion were insuf-
ficient clinical data; irregular follow-up, treatment, or life-
style; association of partial seizures; and follow-up period 
<1 year. Among the 144 patients with JME, 110 of them 
had regular follow-ups for at least 1 year and were included 
in this study. Four of the 144 patients had additional partial 
seizures, which was confirmed with long-term video-EEG 
monitoring, and were excluded from the study. All the pa-
tients were seen by the same neurologists with an inter-
est in epilepsy, and the diagnosis of JME was confirmed 
based on the clinical and EEG findings, using the follow-
ing  International  League  Against  Epilepsy  classification 
criteria for epilepsies and epileptic syndromes: myoclonic 
jerks with or without an association to generalized tonic-
clonic (GTC) seizures or absence seizures, onset in puberty, 
and normal neurological examination.[2] A detailed history 
of the type and frequency of the seizures was obtained 
from the patients, parents, and other relatives. We classi-
fied each seizure type and its evolution according to the 
semiologic seizure classification. Focal semiologic features 
included auras, asymmetrical or unilateral myoclonic jerks, 
focal  tonic  seizures,  focal  clonic  seizures,  asymmetrical 
tonic limb posturing, and version before the tonic phase of 
the GTC seizures. All of the patients had regular follow-up 
visits every 3-6 months at our Epilepsy Department. Each 
visit included a neurological examination, survey of the 
frequency of each seizure type, and routine blood analysis.
The EEG evaluation was performed and analyzed at the 
same institution. The standard placement of 10-20 elec-
trodes was used for the EEG recordings. The standard re-
cording  phase  lasted  20  min  and  the  hyperventilation 
phase  lasted  4  min.  Intermittent  photic  stimulation  was 
performed with frequencies of 5, 10, 15, and 20 flashes/s, 
and 0.5 and 70 Hz filters were used. The interictal EEG find-
ings for each patient were analyzed for any focal or gener-
alized features. Focal interictal EEG findings were defined 
as isolated regional slow waves and regional epileptiform 
discharges (sharp, spike, spike-wave complexes, or poly-
spikes), whereas generalized features were defined as gen-
eralized irregular slow waves and generalized epileptiform 
activity.  Focal  or  lateralized  epileptiform  abnormalities 
(hemispheric predominance) and generalized epileptiform 
abnormalities on the EEGs of the patients were also defined.   
Results
We included 110 consecutive patients (85 female and 25 
male) with a clinical diagnosis of JME. The mean age at 
first evaluation was 24.7 years (range, 14 to 58 years). The 
mean age at onset of epilepsy was 14.5 years (range, 5 to 
25 years). The mean delay between the first seizure and the 
diagnosis of JME was 5.4±4.2 years. 
Nine of the 110 patients (8.2%) had a history of febrile con-
vulsions and 30 of the 110 patients (27.3%) had a history 
of epilepsy in their first-degree relatives. No patient had a 
history of any major disease, and the neurological examina-
tions were normal in all cases. Brain magnetic resonance im-
aging (MRI) was performed on 33 patients, and brain com-
puterized tomography (CT) was performed on 43 patients.
Seizures
The  most  common  clinical  presentation  was  myoclonic 
and  GTC  seizures  together  (66  patients,  60%),  whereas 
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ble 1 shows the seizure types of the 110 patients included 
in this study. 
Eighty-three patients (75.5%) had typical generalized sei-
zures, whereas 27 patients (24.5%) had seizures with focal 
clinical features. Twelve patients had an aura before the 
symmetrical GTC seizures, without any other focal clini-
cal features. Therefore, these 12 patients were identified 
as distinctive. Except for the patients with these isolated 
auras, 15 patients had focal clinical features. Asymmetrical 
myoclonic seizures were recorded in 8 patients, asymmet-
rical tonic limb posturing during GTC seizures were record-
ed in 3 patients, auras and versive head and eye deviations 
during GTC seizures were recorded in 1 patient, and head 
and eye deviations during GTC seizures without auras were 
described in 3 patients. 
EEG
At least two EEGs were obtained from all the patients. The 
number of EEGs per patient ranged from 2-6 (mean, 3.2), 
with a total of 352 tracings. Sleep EEGs were performed in 
86 patients. Table 2 summarizes the EEG findings.
The EEGs showed characteristic generalized abnormalities 
in 55 of the 110 patients (50%). Generalized typical abnor-
malities  and  additional  focal  or  lateralized  (hemispheric 
predominance)  abnormalities  were  observed  in  20  pa-
tients (18.1%). Isolated focal abnormalities were observed 
in 13 patients (11.8%). None of these 13 patients had any 
clinical focal semiologic features. The EEG was always nor-
mal in 17 patients.
Treatment
Ninety-eight patients (89%) received monotherapy and 12 
patients received polytherapy. The most common single-
drug regimen utilized valproic acid (91 patients, 82.7%). 
Table 3 shows the drug regimens used with the patients.
Prognosis
The average follow-up period was 3.5 years (range, 1 to12 
years) at our epilepsy unit. Regarding the prognosis, pa-
tients were divided into three groups. Patients were con-
sidered to be ‘seizure free’ if they had not had a seizure for 
at least 1 year. Patients were classified as having a ‘good 
prognosis’ if they only had isolated, rare myoclonic jerks in 
response to severe precipitant factors. Patients were classi-
fied with a ‘poor prognosis’ if their seizures continued, with 
or without a reduction in frequency. Eighty-two of the 110 
patients (74.5%) were seizure free, 18 patients (16.4%) had 
a good prognosis, and the remaining 10 patients (9.1%) 
had a poor prognosis. All patients with isolated myoclonic 
jerks (13 of the 110 patients) and additional absence sei-
zures (11 of the 110 patients) were considered seizure free. 
Seven of the 10 patients with a poor prognosis had focal 
clinic features or isolated focal EEG abnormalities. Further-
more, 1 of the 10 patients with a poor prognosis had focal 
plus generalized EEG abnormalities, and 1 of the 10 pa-
tients with a poor prognosis had focal clinic features along 
with focal plus generalized EEG abnormalities. Auras were 
recorded in 14 patients, which occurred prior to typical 
symmetrical GTC seizures in 13 of these patients; all 13 of 
these patients were seizure free. Except for isolated auras, 
focal clinical features were observed most frequently in 
patients with a poor prognosis. Focal epileptiform abnor-
malities were observed the least in patients of the seizure-
free group (2 of 82 patients). The frequencies for the focal 
clinical and EEG abnormalities are summarized in Table 4. 
Despite adequate treatment, 10 of the 110 patients were 
medically  intractable.  Table  5  shows  the  demographic 
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Table 1.  Types of seizures of patients
Seizure type  No. of Patients
Myoclonic jerks only  13 (11.8%)
Myoclonic + GTC seizures  66 (60%)
Myoclonic + Absence seizures  11 (10%)
Myoclonic + Absence + GTC seizures  20 (18.2%)
GTC: Generalized tonic-clonic.
Table 2.  EEG findings of  patients
EEG  No. of Patients
Generalized epileptiform activity  55 (50%)
Generalized irregular slow waves  3 (2.7%)
Generalized + focal epileptiform activity  20 (18.1%)
Focal epileptiform activity  13 (11.8%)
Focal irregular slow waves  2 (1.8%)  
Normal  17 (15.4%)data, clinical and EEG findings, and treatment of the pa-
tients with a poor prognosis.
Discussion
Typical cases of JME manifest as bilateral symmetrical sei-
zures and abnormal EEG patterns.[2] Clinical or EEG focal-
ity, asymmetry, or both may lead to misdiagnosis of JME in 
some patients.[9]
The most important element in the diagnosis of JME is 
the patient’s history. Myoclonic jerks are seen in 100% of 
the cases of JME and are necessary for the diagnosis. Myo-
clonic  jerks  are  brief,  bilateral,  usually  symmetrical,  and 
predominantly involve the shoulders and arms. Some jerks 
occur  unilaterally,  which  may  mislead  doctors  toward  a 
diagnosis of focal motor seizures.[10] Predominantly unilat-
eral jerks were reported by 8 of our patients (7.2%), and 5 
of these patients had been misdiagnosed as having focal 
motor seizures. GTC seizures occuring in patients with JME 
are often characterized by an absence of auras, symme-
try, remarkable violence, and a long-duration tonic phase. 
Atypical focal clinical features, such as version of the head 
or eyes or both, focal tonic seizures, focal clonic seizures, 
asymmetrical  tonic  limb  posturing,[11]  versive  or  circling 
seizures,[12,13]  have  been  associated  with  some  patients 
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with JME. In our study, asymmetrical tonic limb postur-
ing during GTC seizures were recorded in 3 patients, and 
versive head and eye deviations during GTC seizures were 
recorded in 4 patients. None of our patients had circling 
seizures. 
EEGs were important for confirming or suggesting the ap-
propriate diagnosis for the patients with JME. EEG abnor-
malities  have  classically  been  reported  as  characterized 
by generalized polyspike and slow-wave discharges that 
predominate  in  the  frontal  regions.  Other  EEG  findings 
include spike and wave complexes, single spikes, and ir-
regular  slow-wave  complexes.[14]  Asymmetrical  general-
ized discharges and focal abnormalities (either indepen-
dent or associated with generalized paroxysms) may be 
observed  in  some  patients  with  JME.[3,11,14,15] These  focal 
abnormalities may present as focal slow waves, spikes, or 
sharp waves, which may lead to a misdiagnosis of partial 
epilepsy. Several authors reported focal or asymmetrical 
EEG abnormalities or both; however, the mechanisms for 
these abnormalities are unclear. One possible mechanism 
for repeated generalized epileptiform activities associated 
with  focal  cortical  pathology  is  microdysgenesis.[16]  An 
alternative explanation is provided by the telencephalic 
theory which states that the cortex is diffusely excitable.[17] 
Thirty-five of our 110 patients (31.8%) had focal EEG abnor-
Table 3.  Treatment schedule of the patients
  Monotherapy   Polytherapy
Treatment  No. of Patients  Treatment  No. of Patients
VPA  91 (82.7%)  VPA+LTG  6 (5.5%)
LTG  4 (3.6%)  VPA+TP  1 (0.09%)
TP  1 (0.09%)  VPA+LVT  1 (0.09%)
LVT  2 (1.8%)  VPA+CLN  2 (1.8%)
    VPA+LTG+CLN  2 (1.8%)
Total  98 (89.0%)    12 (11.0%)
CLN: Clonazepam; LTG: Lamotrigine; LVT: Levetiracetam; TP: Topiramate; VPA: Valproic acid.
Table 4.  Focal clinical features and focal plus generalized EEG abnormalities of the patients.
  Seizure Free (n=82)  Good Prognosis (n=18)  Poor Prognosis (n=10)
FCF (15/110)  8 (9.7%)  4 (22.2%)  4 (40.0%)            
FEA (13/110)  2 (2.4%)  7  (38.8%)  4 (40.0%)          
FEA+GEA (20/110)  11 (13.4%)  7 (38.8%)  2 (20%) 
FCF: Focal clinic features; FEA: Focal epileptiform abnormalities; GEA: Generalized epileptiform abnormalities.malities. Twenty of these 35 patients had focal abnormali-
ties associated with generalized epileptiform abnormali-
ties, 13 had isolated focal epileptiform abnormalities, and 
2 of them had focal irregular slow waves. 
Despite the well-known clinical features of patients with 
JME,  there  is  insufficient  data  regarding  the  risk  factors 
associated  with  the  intractable  nature  of  this  disorder. 
Seizures  are  generally  well  controlled  with  appropriate 
medication in approximately 90% of patients.[18] However, 
it is of vital importance to identify what characteristics dis-
tinguish the patients that fall into the remaining 10% of 
the patient population and how we can determine their 
prognosis. 
Few  studies  address  what  features  are  associated  with 
poor seizure control in patients with JME. Jain et al.[19] stud-
ied 15 patients with JME with myoclonic jerks alone and 
hypothesized  that  those  patients  presenting  with  early 
morning  myoclonic  jerks  only  may  represent  a  benign 
variant of the disorder. Our results supported the findings 
of this report because 13 patients (11.8%) in the present 
study had myoclonic seizures alone, and all of them were 
considered seizure free. Matsuoka[4] reported an excellent 
prognosis for 32 patients diagnosed with JME that had ab-
sence seizures and myoclonic jerks. The seizures were well 
controlled in the patients with absence seizures compared 
to patients with generalized tonic-clonic seizures or pa-
tients with generalized tonic-clonic seizures plus absence 
seizures. Gelisse et al.[6] studied 155 patients with JME and 
found two independent situations that were significantly 
associated with poor therapeutic control of the disorder: 
the coexistence of all three seizure types (myoclonic jerks, 
absence seizures, and GTC seizures) and the existence of 
psychiatric problems. There were no cases of drug resis-
tance in the patients that experienced isolated myoclonic 
jerks only or a combination of myoclonic jerks and absence 
seizures.[6] In accordance with the findings of these reports, 
additional absence seizures were observed in 11 patients 
in our study (10%), and all of them were considered seizure 
free. Six of 10 intractable patients with JME in the present 
study had GTC seizures, and the remaining 4 patients had 
all three types of seizures. Ours was a retrospective study, 
so we cannot provide details regarding the neuropsycho-
logical status of the patients.
Dasheiff and Ritaccio[5] identified 12 patients with intrac-
table JME who had a long duration of epilepsy (the diag-
nosis and treatment were delayed) and a high percent-
age of asymmetrical or focal discharges with scalp EEGs. 
The average duration of epilepsy in these patients was 21 
years. Those authors thought that JME was not necessarily 
a benign epilepsy and suggested that alternative thera-
pies, such as epilepsy surgery, may be indicated. Fernando-
Dongas et al.[8] studied 33 patients with JME and found that 
23 patients were sensitive to valproic acid (VPA) and 10 pa-
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Table 5.  Clinical characteristics of the 10 patients with a poor prognosis
No.  Age/Sex  Types of Seizures  Clinical Features  EEG  Treatment  Follow-up (months)
1  19/M  MJ+GTC  Typical  FEA   VPA  72  
2  29/M  MJ+GTC  Typical  FEA+ GEA  VPA+LTG+CLN  47
3  24/F  MJ+GTC+A  Typical  FEA  VPA+LTG  35
4  48/F  MJ+GTC  Typical  FEA  VPA+LTG  94
5  30/F  MJ+GTC+A  Typical  GEA  VPA+TP  91
6  24/F  MJ+GTC+A  Typical  FEA  LVT  22
7  16/F  MJ+GTC+A  FCF1  GEA  VPA+LTG  23
8  17/F  MJ+GTC  FCF2  GEA  VPA+LTG  24
9  42/F  MJ+GTC  FCF3  FEA+GEA  VPA  16
10  19/F  MJ+GTC  FCF2  GEA  VPA  18
A: Absence seizures; CLN: Clonazepam; F: Female; FCF: Focal clinic features; FEA: Focal epileptiform abnomalities; GEA: Generalized epileptiform abnormaliti-
es; GTC: Generalized tonic-clonic seizures; LTG: Lamotrigine; LVT: Levetiracetam; M: Male; MJ: Myoclonic jerks; TP: Topiramate; VPA: Valproic acid.
1Aura and versive head and eye deviations during GTC seizures.
2Asymmetric tonic limb posturing during GTC seizures.
3Asymmetric myoclonic jerks. tients were resistant. The VPA-resistant group had a higher 
frequency of EEG asymmetries, atypical seizure character-
istics including auras and post-ictal confusion, and intellec-
tual deficiencies. The average duration of epilepsy for our 
patients was 11.2 years in the seizure-free group and 13.3 
years in the poor prognosis group. The epilepsy duration 
for these two groups was not significantly different from 
one another, and we did not find any relationship between 
a long duration of epilepsy and poor prognosis in patients 
with JME. In our study, the EEG patterns revealed that 6 of 
10 patients (60%) in the poor prognosis group and 13 of 
82 patients (15.8%) in the seizure-free group had isolated 
focal  epileptiform  abnormalities,  or  focal  or  lateralized 
epileptiform plus generalized epileptiform EEG abnormali-
ties. In accordance with these reports, we found that focal 
EEG abnormalities were associated with a poor prognosis. 
In our study, auras occurred before the GTC seizures in 13 
of 110 patients (11.8%). Only 1 patient (of 10) in the poor 
prognosis group described versive head and eye devia-
tions during GTC seizures that followed an aura. Therefore, 
we did not find any relationship between the presence of 
auras a poor prognosis for JME. None of our patients had 
post-ictal  confusion  following  absence  seizures  or  myo-
clonic seizures.
Gelisse et al.[7] investigated the influence of structural brain 
lesions on the prognosis for JME in 82 patients. These au-
thors confirmed that structural brain lesions were unre-
lated to the prognosis for patients with JME, and neuro-
imaging  procedures  should  not  be  performed  routinely 
in typical cases. In our series, we had brain neuroimaging 
data for 76 patients (MRI for 33 patients, CT for 43 patients) 
and only 11 of the scans were considered abnormal. Five 
of the 10 patients with a poor prognosis received a cranial 
MRI, and the data from all of those patients were normal. 
Therefore, we cannot make any comment about a relation-
ship between brain structure abnormalities and the prog-
nosis for JME. 
Nine of 10 patients (90%) with intractable JME in our se-
ries  had  abnormal  focal  clinical  features,  abnormal  EEG 
features, or both. A few previous studies indentified fo-
cal clinical features in patients with JME;[8,11-13] only two of 
these studies discussed the effects ofn these features on 
patient prognosis. In these two studies, versive seizures or 
circling seizures in idiopathic generalized epilepsy did not 
coincide with a worsened prognosis,[13] and atypical sei-
zure characteristics such as auras and post-ictal confusion 
were associated with the valproic acid-resistant patients 
with JME.[8] This is the first study in the English literature 
in which the results confirmed that the presence of fo-
cal clinical features (asymmetrical or unilateral myoclonic 
jerks, asymmetrical tonic limb posturing, version before the 
tonic phase of GTC) worsened the prognosis for patients 
with JME. In contrast to previous studies, we conclude that 
the presence of isolated auras did not affect the prognosis 
for JME. A relationship between focal or asymmetrical epi-
leptiform abnormalities on EEGs and a poor prognosis for 
JME was determined in previous studies.[5,8] In our study, 
we found that focal or asymmetrical plus generalized EEG 
abnormalites, especially isolated focal EEG features, were 
suggestive of a poor prognosis.
We can summarize our results as follows: 1) Myoclonic jerks 
alone or together with absence seizures were associated 
with a good prognosis; the presence of GTC seizures or all 
three types of seizures were associated with a poor prog-
nosis. 2) Typical clinical and EEG features were associated 
with a good prognosis; the presence of focal clinical or 
EEG abnormalities were associated with a poor prognosis. 
3) Auras, although considered an atypical clinical feature, 
were not associated with a poor prognosis.
Focal clinical features, EEG abnormalities, or both in pa-
tients with JME are not uncommon. Clinicians should be 
aware  of  these  atypical  features  and  be  aware  of  their 
negative influence on prognosis while following these pa-
tients.
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